Skip to main content
. 2021 May 12;10(12):3873–3885. doi: 10.1002/cam4.3929

FIGURE 2.

FIGURE 2

(A) Frequency of variants detected with ctDNA before treatment with osimertinib. (B) Allele fraction of T790 M and EGFR activating mutations with ctDNA before treatment with osimertinib. SNV, single‐nucleotide variant; CNV, copy number variant